neurodegenerative diseases

Study lays the groundwork for potential new therapies for progressive multiple sclerosis

Protein deposits in retina and brain appear to parallel possible neurodegeneration

Outreach Pro aimed at increasing underrepresented population participation

The relationship between cognitive decline, bone loss, and fracture risk may be driven by shared risk factors

Neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients

Methodology for analyzing high-risk pedigrees can be used to prioritize rare genetic variants

With rapid advancements in isolation and purification techniques, the potential role of exosomes as biomarkers in disease pathogenesis is becoming clearer

International clinical trial yields mixed results with unclear cognitive effects but promising biomarker results

New validation study shows potential use of neurofilament light chain in primary care settings 

National survey of MS specialists finds nearly 10 percent redeployed to the front lines of COVID-19 patient care